Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
37
|
pubmed:dateCreated |
1989-1-5
|
pubmed:abstractText |
In a preliminary study of 21 febrile episodes in neutropenic patients ceftazidime used as empirical treatment in doses of 3 grams per day succeeded in controlling fever in 74 per cent of the cases. Laboratory studies performed in patients with Gram-negative septicaemia showed clinically effective plasma concentrations of the antibiotic. A trial of ceftazidime (3 g/day) administered alone or combined with amikacin or vancomycin is currently in progress in two medical centres. No statistically significant conclusions could be reached from an intermediate study.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0755-4982
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1968-70
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2973598-Agranulocytosis,
pubmed-meshheading:2973598-Amikacin,
pubmed-meshheading:2973598-Bacterial Infections,
pubmed-meshheading:2973598-Ceftazidime,
pubmed-meshheading:2973598-Clinical Trials as Topic,
pubmed-meshheading:2973598-Drug Therapy, Combination,
pubmed-meshheading:2973598-Fever,
pubmed-meshheading:2973598-Humans,
pubmed-meshheading:2973598-Neutropenia,
pubmed-meshheading:2973598-Random Allocation,
pubmed-meshheading:2973598-Vancomycin
|
pubmed:year |
1988
|
pubmed:articleTitle |
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
|
pubmed:affiliation |
Service d'Hématologie, Institut Gustave Roussy, Villejuif.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial
|